Du är här

2016-05-12

OMX AB: NASDAQ STOCKHOLM WELCOMES WILSON THERAPEUTICS TO THE MAIN MARKET

Nasdaq Nordic

NASDAQ STOCKHOLM WELCOMES WILSON THERAPEUTICS TO THE MAIN MARKET

Stockholm, May 12, 2016 — Nasdaq (Nasdaq: NDAQ) announced that Wilson
Therapeutics AB (short name: WTX), a mid cap company within the health care
sector, has started trading of its shares on the main market of Nasdaq
Stockholm. Wilson Therapeutics is the 26th company to list at Nasdaq’s Nordic
markets* in 2016.

Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden,
focused on developing novel therapies addressing unmet, medical needs in rare
diseases. The company is committed to the development of its lead product,
Decuprate, which is initially developed as a new treatment for Wilson Disease.
Wilson Disease is a rare, genetic disease that causes serious copper poisoning,
affecting approximately one in every 30 000 people worldwide. For more
information, please visit www.wilsontherapeutics.com

“The listing on the Stockholm Stock Exchange is a significant milestone in the
Company’s development history,” said Jonas Hansson, CEO of Wilson Therapeutics.
“We are very pleased that we have secured the financing to continue to develop
Decuprate all the way to the market with the goal of offering patients with
Wilson Disease a novel therapy that addresses the large medical need that
exists.”

“We are excited to welcome Wilson Therapeutics to the Nasdaq Stockholm main
market,” said Adam Kostyál, senior vice president and head of European listings
at Nasdaq. “Wilson Therapeutics joins our strong and growing health care
sector, and we look forward to supporting them on their journey as a publicly
traded company.”

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki,
Nasdaq Iceland and Nasdaq Stockholm.

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange
technology, listing, information and public company services across six
continents. Through its diverse portfolio of solutions, Nasdaq enables
customers to plan, optimize and execute their business vision with confidence,
using proven technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first electronic
stock market, its technology powers more than 70 marketplaces in 50 countries,
and 1 in 10 of the world's securities transactions. Nasdaq is home to more than
3,700 listed companies with a market value of over $9.3 trillion and nearly
17,000 corporate clients. To learn more, visit nasdaq.com/ambition or
business.nasdaq.com.

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq
Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker
Services are respectively brand names for the regulated markets of Nasdaq
Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS,
Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB
and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq
Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq
Vilnius.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made
under the Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995. These statements include, but are not limited to, statements about
Nasdaq and its products and offerings. We caution that these statements are not
guarantees of future performance. Actual results may differ materially from
those expressed or implied in the forward-looking statements. Forward-looking
statements involve a number of risks, uncertainties or other factors beyond
Nasdaq's control. These factors include, but are not limited to factors
detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed
with the U.S. Securities and Exchange Commission. We undertake no obligation to
release any revisions to any forward-looking statements.

Media Relations Contact:
Erik Granström
+46 73 449 78 07
erik.granstrom@nasdaq.com
-------------------------

Författare SSE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.